Secretary General Indian Pharmaceutical Alliance
2023 : A Transformative Year for Indian Pharma Industry
C O V E R S T O R Y
Sudarshan Jain
Secretary General Indian Pharmaceutical Alliance
2023 : A Transformative Year for Indian Pharma Industry
The Indian pharma industry is a knowledge-driven and strategic sector for the nation with the advantage of depth and scale . The year 2023 has been a transformational year for the sector which witnessed multiple initiatives catalysing innovation , quality and access . The Government announced the Promotion of Research & Innovation Program ( PRIP ) Scheme , MedTech Policy , Approach Paper on
National Pharma Policy and displayed thrust on “ One Health ” during the G20 Summit . These initiatives are in continuation of Production Linked Incentive ( PLI ) 1.0 , Bulk Drug Park and PLI 2.0 Schemes and are aimed at self-reliance and making global champions from India . The convergence of policy thrust , and India ’ s entrepreneurial vigour will propel the sector ’ s growth and ensure a consistent supply of quality-assured affordable medicines for patients both in India and globally .
38
BioVoiceNews | January / February 2024